VBI Vaccines Inc. (Nasdaq: VBIV) to Ring The Nasdaq Stock Market Opening Bell
July 19 2016 - 10:00AM
What: VBI Vaccines Inc.
(“VBI”) (Nasdaq:VBIV), a commercial-stage biopharmaceutical company
developing a next generation of vaccines to address unmet needs in
infectious disease and immuno-oncology, will visit the Nasdaq
MarketSite in Times Square.
In honor of the occasion, Jeff Baxter,
President and Chief Executive Officer, will ring the
Opening Bell.
Where:Nasdaq MarketSite – 4 Times
Square – 43rd & Broadway – Broadcast Studio
When:Wednesday, July 20, 2016 –
9:15 a.m. to 9:30 a.m. ET
VBI Media Contact:Perri
Maduri617-830-3031 x124pmaduri@vbivaccines.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line
(Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811
Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia
features such as exclusive content, photo postings, status updates
and video of bell ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit
our Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please
visit our YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos,
please visit our Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the
Nasdaq Opening Bell will be available at:
https://new.livestream.com/nasdaq/live or
http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution
photograph of the Market Open, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market open of your choice.
About VBIVBI Vaccines Inc.
(Nasdaq:VBIV) is a commercial-stage biopharmaceutical company
developing a next generation of vaccines to address unmet needs in
infectious disease and immuno-oncology. VBI’s first marketed
product is Sci-B-Vac™, a hepatitis B (“HBV”) vaccine that mimics
all three viral surface antigens of the hepatitis B virus;
Sci-B-Vacis approved for use in Israel and 14 other countries.
VBI’s eVLP Platform technology allows for the development of
enveloped (“e”) virus-like particle (“VLP”) vaccines that closely
mimic the target virus to elicit a potent immune response. VBI is
advancing a pipeline of eVLP vaccines, with lead programs in
cytomegalovirus (“CMV”) and glioblastoma multiforme (“GBM”). VBI is
also advancing its LPV™ Thermostability Platform, a proprietary
formulation and process that allows vaccines and biologics to
preserve stability, potency, and safety. VBI is headquartered in
Cambridge, MA with research operations in Ottawa, Canada and
research and manufacturing facilities in Rehovot, Israel.
About NasdaqNasdaq (Nasdaq:NDAQ)
is a leading provider of trading, clearing, exchange technology,
listing, information and public company services across six
continents. Through its diverse portfolio of solutions, Nasdaq
enables customers to plan, optimize and execute their business
vision with confidence, using proven technologies that provide
transparency and insight for navigating today's global capital
markets. As the creator of the world's first electronic stock
market, its technology powers more than 70 marketplaces in 50
countries, and 1 in 10 of the world's securities transactions.
Nasdaq is home to more than 3,700 listed companies with a market
value of approximately $9.3 trillion and nearly 17,000 corporate
clients. To learn more, visit: nasdaq.com/ambition or
business.nasdaq.com.
-NDAQA-
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Sep 2023 to Sep 2024